BENDHEIM JACK (President and CEO) sold 7.4% of their position (1.24K shares) of PHIBRO ANIMAL HEALTH CORP on the open market
Open‑market sale worth $50.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/27/2026ACC: 0001104659-26-006986
DirectorOfficer10% Owner· President and CEO
Since Jul 2018
-1.24K
Net shares
Net seller
$50.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
30K acquired · 31.23K disposed
Non-Derivative Transactions2
Class A Common Stock
Indirect
Shares
−1.24K
Price / share
$40.55
Trade value
$50.08K
% of position
7.4%
1/23/2026
16.68K→15.45K
Class A Common Stock
Indirect
Shares
+30K
Price / share
—
Trade value
—
% of position
194.2%
1/26/2026
15.45K→45.45K
Total
Net shares
+28.77K
Net value
-$50.08K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Indirect | 1/23/2026 | S · Sale | −1.24K | $40.55 | $50.08K | 7.4% | 16.68K | 15.45K |
| Class A Common Stock Indirect | 1/26/2026 | C · Conversion | +30K | — | — | 194.2% | 15.45K | 45.45K |
| Total | +28.77K | -$50.08K | ||||||
Derivative Transactions1
Class B Common Stock
Indirect
Converts to
Class A Common Stock
30K shares
Shares
−30K
Strike price
0
Held after
19.91M
Exercisable
—
1/26/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Class B Common Stock Indirect | Class A Common Stock30K shares | 1/26/2026 | C · Conversion | −30K | 0 | — | 19.91M |
Non-Derivative Holdings (Post-Transaction)1
Class A Common Stock
DirectShares owned16.84K
Total
16.84K direct16.84K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 16.84K | Direct |
| Total | 16.84K | 16.84K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported